Judge Tosses Expert Testimony From Celebrex Case
A federal judge has refused to allow expert testimony in the multidistrict product liability litigation that connects Pfizer Inc.'s anti-inflammatory drug Celebrex, in its most common dosage, with increased risks of...To view the full article, register now.
Already a subscriber? Click here to view full article